NCT04056832

Brief Summary

Aortic stenosis is a commonly found heart disease, which often leads to mortality and morbidity. Valve replacement using mechanical prosthetic valve will have an expensive cost especially in the Integrated Heart Center of Cipto Mangunkusumo Hospital, Jakarta, Indonesia. In addition to the expensive cost, patients who have mechanical prosthetic valve have an increased risk of infection of the prosthetic valve and developing thrombo-embolism thus have to consume a lifelong anticoagulant therapy that increase risk of bleeding. A surgical technique using autologous pericardium is an alternative to prosthetic valve replacement, one of which is a single pericardium strip technique that uses modified autologous pericardium technique from Ozaki et al and Duran et al. The objective of this study is to investigate the outcome of aortic valve replacement with a single pericardium strip of autologous pericardium in patients with aortic stenosis. This study will be conducted at the Integrated Heart Center of Cipto Mangunkusumo Hospital, Jakarta, Indonesia, by using quasi experimental type time series design. Subjects are patients with aortic stenosis who are candidates for valve replacement. Inclusion criteria is having low to moderate surgical risk (EuroScore II \<5). The sampling method used in this study is non-probability consecutive sampling. This study will assess the outcome of the aortic valve replacement (valve hemodynamic, left ventricular reverse remodelling, sST2, 6MWT) at 3 months and 6 months post-aortic valve replacement. It is expected that aortic valve replacement using a single strip of autologous pericardium will have good valve hemodynamic outcome, yield left ventricular reverse remodelling, decrease sST2 level, show upgrade in 6MWT, and have shorter aortic cross clamp time so that it can be an alternative to aortic valve replacement using mechanical prosthetic valve that is less expensive and have good outcomes in patient with aortic stenosis.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
62

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2017

Completed
1.8 years until next milestone

First Submitted

Initial submission to the registry

February 1, 2019

Completed
6 months until next milestone

First Posted

Study publicly available on registry

August 14, 2019

Completed
5 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 20, 2020

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

April 20, 2020

Completed
Last Updated

August 14, 2019

Status Verified

August 1, 2019

Enrollment Period

2.8 years

First QC Date

February 1, 2019

Last Update Submit

August 13, 2019

Conditions

Keywords

Aortic StenosisAortic Valve ReplacementSingle Strip PericardiumAutologous PericardiumMechanical Valve ReplacementComparison of Left Ventricle Remodeling

Outcome Measures

Primary Outcomes (6)

  • Change in Left Ventricular End Diastolic Diameter

    Left Ventricular End Diastolic Diameter in mili meters assessed by Trans-thoracic Echocardiography measurement on M-mode

    before surgery, 3 months and 6 months after surgery

  • Change in Left Ventricular End Systolic Diameter

    Left Ventricular End Systolic Diameter in mili meters assessed by Trans-thoracic Echocardiography measurement on M-mode

    before surgery, 3 months and 6 months after surgery

  • Change in Ejection Fraction Percentage

    Ejection Fraction Percentage assessed by Trans-thoracic Echocardiography with modified Simpson's volumetric method (BiPlane measurement: apical 4 chambers and apical 2 chambers)

    before surgery, 3 months and 6 months after surgery

  • Change in 6 Minute Walking Test Performance (meters)

    Subjects will be asked to walk for six minutes on a given track then the distance achieved will be measured in meters

    before surgery, 3 months and 6 months after surgery

  • Change in 6 Minute Walking Test Performance (METs)

    The result of distance in meters of the six minute walking test will be converted to VO2max by the given formula: (distance in meters x 0.03) + 3.98 = VO2max Then the VO2max will be converted to METs by given formula: VO2max : 3.5 = METs

    before surgery, 3 months and 6 months after surgery

  • Change in Soluble Suppression of Tumorigenicity-2 (sST2) Level

    Level of soluble Suppression of Tumorigenicity-2 measured in nano gram per mili Liters (ng/mL) by quantitative sandwich enzyme immunoassay technique assessed with Quantikinine Elisa

    before surgery, 3 months and 6 months after surgery

Secondary Outcomes (11)

  • Coaptation Height of Aortic Valve Leaflet in mili meters

    at the time of surgery

  • Effective Height of Aortic Valve in mili meters

    at the time of surgery

  • Aortic Jet Velocity Value in m/s

    before surgery

  • Mean Trans-aortic Pressure Gradient Value in mmHg

    before surgery

  • Aortic Stenosis Severity

    before surgery

  • +6 more secondary outcomes

Other Outcomes (2)

  • Duration of Intensive Care Unit Stay

    at the time of surgery

  • Duration of Ventilator Use

    at the time of surgery

Study Arms (2)

Single Strip Pericardium

EXPERIMENTAL

Aortic Valve Replacement using single strip of patient's autologous pericardium

Procedure: Single Strip Pericardium

Mechanical Prosthetic Valve

ACTIVE COMPARATOR

Aortic Valve Replacement using mechanical prosthetic valve

Procedure: Mechanical Prosthetic Valve

Interventions

The anterior pericardium is taken in accordance with the measurements made using an aortic annulus sizer or Ismail sizer. The diameter of the annulus valve is converted to circumference of the aortic valve according as a measure of the length of the pericardium. Measurement of aortic commissure height is done by measuring the distance between the lowest point of the valve attachment to the highest point on the commissure as a measure of pericardium width. The pericardium is immersed in 0.6% glutaraldehyde solution for 10 minutes, then rinsed and soaked with saline solution 3 times for 6 minutes each. After the pericardium becomes firm it is cut to be a single strip according to the length and width in the previous measurement. It is then sutured to the aortic valve annulus.

Also known as: Autologous Pericardium
Single Strip Pericardium

Median incision is performed at the surgical site. Sternal retractor is placed at the sternum after median sternotomy being performed. Aortic valve is measured using aortic annulus sizer. Pledgeted suture is performed for the mattress. Sutures are performed to attach the mechanical prosthetic to the aortic annulus.

Mechanical Prosthetic Valve

Eligibility Criteria

Age10 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Patients aged more than 10 years old
  • Patients with aortic valve stenosis with an indication of aortic valve replacement having low to moderate surgical risk (EuroScore II \<5)
  • The patient or guardian (the research subject's parent) agrees to follow the study

You may not qualify if:

  • Patients who have previously underwent aortic valve replacement
  • Patients with aortic stenosis due to bicuspid aortic valve
  • Patients with autoimmune disease
  • Patients with mixed connective tissue disease

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Cipto Mangunkusumo Central National Hospital

Jakarta, DKI Jakarta, 10430, Indonesia

RECRUITING

Related Publications (4)

  • d'Arcy JL, Prendergast BD, Chambers JB, Ray SG, Bridgewater B. Valvular heart disease: the next cardiac epidemic. Heart. 2011 Jan;97(2):91-3. doi: 10.1136/hrt.2010.205096. Epub 2010 Dec 13. No abstract available.

  • Coffey S, Cairns BJ, Iung B. The modern epidemiology of heart valve disease. Heart. 2016 Jan;102(1):75-85. doi: 10.1136/heartjnl-2014-307020. Epub 2015 Nov 5. No abstract available.

  • Osnabrugge RL, Mylotte D, Head SJ, Van Mieghem NM, Nkomo VT, LeReun CM, Bogers AJ, Piazza N, Kappetein AP. Aortic stenosis in the elderly: disease prevalence and number of candidates for transcatheter aortic valve replacement: a meta-analysis and modeling study. J Am Coll Cardiol. 2013 Sep 10;62(11):1002-12. doi: 10.1016/j.jacc.2013.05.015. Epub 2013 May 30.

  • Maganti K, Rigolin VH, Sarano ME, Bonow RO. Valvular heart disease: diagnosis and management. Mayo Clin Proc. 2010 May;85(5):483-500. doi: 10.4065/mcp.2009.0706.

MeSH Terms

Conditions

Aortic Valve StenosisAortic Valve, Calcification of

Condition Hierarchy (Ancestors)

Aortic Valve DiseaseHeart Valve DiseasesHeart DiseasesCardiovascular DiseasesVentricular Outflow Obstruction

Study Officials

  • Ismail Dilawar, doctor

    Fakultas Kedokteran Universitas Indonesia

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Ismail Dilawar, doctor

CONTACT

Nusaibah N Juliafina, doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 1, 2019

First Posted

August 14, 2019

Study Start

April 20, 2017

Primary Completion

January 20, 2020

Study Completion

April 20, 2020

Last Updated

August 14, 2019

Record last verified: 2019-08

Data Sharing

IPD Sharing
Will not share

Locations